TABLE 2.
Heterogeneity and Methodological Limitations Found in Studies Investigating Children and Adolescents With Persistent Symptoms After SARS-CoV-2 Infection
| Heterogeneity between studies |
| Studies vary considerably in: |
| • Age range of participants |
| • Proportion of participants with preexisting medical conditions |
| • Inclusion criteria |
| ∘ Laboratory confirmed COVID |
| ∘ Severity of disease |
| • Time points of assessment |
| • Outcome measurement |
| ∘ Number and range of symptoms assessed |
| ∘ Duration of follow-up |
| • Data collection method |
| Methodologic limitations |
| • No control group |
| • Small cohort or small number seropositive |
| • No data on preexisting medical conditions |
| • Inclusion criteria |
| ∘ Includes self-reported SARS-CoV-2 infection |
| ∘ Not all cases laboratory confirmed infection |
| ∘ Includes only/mostly asymptomatic or mild infection |
| • Outcome |
| ∘ Timing of SARS-CoV-2 infection not specified |
| ∘ Duration of symptoms not specified |
| ∘ Self-/parent-reported symptoms, no clinical assessment |
| ∘ Few clinical outcomes assessed |
| ∘ No mental health outcomes |
| • Bias |
| ∘ Selection bias |
| ∘ Misclassification bias |
| ∘ Recall bias |
| ∘ Nonresponse bias |